We intend to focus our search on businesses in the cannabis industry that are compliant with all applicable laws and regulations within the jurisdictions in which they are located or operate. In particular, we will not invest in, or consummate a business combination with, a target business that we determine has been operating, or whose business plan is to operate, in violation of U.S. federal laws, including the U.S. Controlled Substances Act. 

(Clover Leaf Capital Corp. priced its SPAC IPO on July 19, 2021, in sync with the terms in its prospectus: 12.5 million units at $10 each to raise $125 million.)